“Biden Cancer Moonshot & Cancer Health Policy” | Dr. Kamal Menghrajani

Kamal Menghrajani, MD
Assistant Director, Cancer Innovation and Public Health
The White House Office of Science and Technology Policy

Kamal Menghrajani, MD, MS serves as the Assistant Director for Cancer Innovation and Public Health at the White House Office of Science and Technology Policy (OSTP). Dr. Menghrajani is the first oncologist to be embedded with the Biden Cancer Moonshot team at the White House and was previously a 2023-2024 White House Fellow. Prior to joining OSTP, Dr. Menghrajani was a practicing hematologist / medical oncologist on faculty at Memorial Sloan Kettering Cancer Center, where she treated patients with leukemia and conducted computational oncology research in clonal myeloid disorders. She was the recipient of an ASCO YIA and an NIH K12, and earned an MS in Biostatistics at the Mailman School of Public Health. She also has had experience working in global health, medical journalism, and social entrepreneurship.

JOIN HERE!

Dr. Menghrajani’s objectives:

• • Analyze the history of the Cancer Moonshot
  • Name at least one Cancer Moonshot Program
  • Have an improved understanding of cancer health policy

FACULTY DISCLOSURE:

Dr. Menghrajani has indicated that she has no relevant financial relationships with commercial interests.

Planning Committee Disclosure

Dr. Lekakis has indicated that he has no relevant financial relationships with commercial interests.

Target Audience

Faculty, Primary Care Physicians, APRNs, PharmD

Accreditation

The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.